Virologists call for rational discourse on gain of function research

8 U-M researchers sign commentary stressing importance of viral research

2:05 PM

Authors | Kelly Malcom | Joanna Urban

Scientists Hazmat Suits Laboratory Vials
Getty Images

The study of viruses is under renewed scrutiny, say more than 150 experts in a new commentary published recently in mSphere, mBio and the Journal of Virology, journals of the American Society for Microbiology.

The commentary’s authors call on policymakers to recognize the need for more rational discourse around the future of virology. They implore a more nuanced, evidence-based discussion around gain of function research and provide evidence to support the benefits of this type of research for human health. These concerns are especially focused on enhanced potential pandemic pathogen research and dual use research of concern.

“To respond rapidly to emerging viral threats we must be able to apply modern biology tools to viruses which will ensure that we reduce the burden of future disease outbreaks,” said Felicia Goodrum, Ph.D., co-Editor-in-Chief of ASM’s Journal of Virology.  

The current debate regarding the origin of SARS-CoV-2 pandemic is partly due to a theory that suggests it may have been caused by an accidental or intentional lab leak. However, evidence strongly suggests that the virus originated from zoonotic transmission, through the transfer of the virus from wild animals to humans.
 
Despite this, a narrative against this valuable research tool has developed, putting the field of virology at risk, despite its critical role in preparing humanity to fight threats posed by viruses.
 
"Research on dangerous pathogens does require oversight, but we must be careful to not overly restrict the ability of scientists to generate the knowledge needed to protect ourselves from these pathogens,” said Michael Imperiale, Ph.D., a professor with the Department of Microbiology and Immunology at the University of Michigan Medical School and editor-in-chief of ASM’s journal mSphere.
 
As policymakers take a renewed look at policies surrounding gain-of-function research, the authors state, the abundance of existing oversight around virology research should be considered and a concerted effort to avoid redundant measures should be implemented.
 
Gain of function research and regulations around virus research was the subject of a meeting by the National Science Advisory Board for Biosecurity held on January 27, 2023 which has released draft findings and recommendations. Imperiale is scheduled to testify at the Congressional hearing "Challenges and Opportunities to Investigating the Origins of Pandemics and Other Biological Events” on February 1, 2023.
 
Read the full commentary: “Virology Under the Microscope: A Call for Rational Discourse.”

Live your healthiest life: Get tips from top experts weekly. Subscribe to the Michigan Health blog newsletter

Headlines from the frontlines: The power of scientific discovery harnessed and delivered to your inbox every week. Subscribe to the Michigan Health Lab blog newsletter

Like Podcasts? Add the Michigan Medicine News Break on Spotify, Apple Podcasts or anywhere you listen to podcasts.

More Articles About:

 Research Future Think Health Care Delivery, Policy and Economics Education Community Health Hospitals & Centers
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact
University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

 Medicaid magnifying glass
Health Lab

What’s changing in Medicaid and what can you do?

With eligibility rules for people with lower incomes changing in every state, it’s important to stay up to date, seek trustworthy sources and not fall for misinformation
 Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
 Well-Being at Michigan Medicine with Dr. Elizabeth Harry
Well-Being at Michigan Medicine

Learning Together: Making Space for Growth at Work

What if well-being starts with how we learn together? On this episode of Well-Being at Michigan Medicine, Elizabeth Harry, M.D., is joined by Rajesh Mangrulkar, M.D., FNAP, Executive Director of U-M’s Center for Interprofessional Practice and Education (IPE), Executive Director of Michigan Medicine RISE (Research. Innovation. Scholarship. Education), and primary care physician of internal medicine whose work focuses on organizational leadership and innovation, and Johnny McGraw, M.A., Marketing & Communications Specialist for both RISE and IPE, about building teams through human connection, psychological safety and learning. They discuss a meeting practice, why leaders shape culture and how investments in collaboration can help health care teams work without asking people to carry everything alone.
 A hand holding a prescription bottle with a dollar bill in it
Health Lab

Top 7 tips for choosing Medicare prescription drug coverage for 2027

Prescription drug coverage through Medicare Advantage and Part D plans in traditional Medicare has changed for 2027, and older adults may not know about programs that could help with costs.
 Two older women looking at the Medicare website on a laptop screen
Health Lab

Many older adults make Medicare decisions quickly and most don’t change plans, poll finds

Sixty percent of older adults spend less than an hour choosing their Medicare coverage during Open Enrollment, a new poll finds.
 pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has announced it will place non-botanical products containing 7-OH on Schedule I, joining three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.